Genetic alterations of HLA-class II in ovarian cancer

作者: Kirsten Kübler , Peter F. Arndt , Eva Wardelmann , Christina Landwehr , Dieter Krebs

DOI: 10.1002/IJC.23624

关键词:

摘要: The immune system controls tumor formation through identification and elimination of cellular alterations. Consequently, cancer development in competent hosts depends on strategies to evade the system. Modulation antigen-specific responses by aberrant expression HLA-class I II molecules is well documented a variety carcinomas including ovarian cancer. To date, little data are available about molecular mechanisms responsible for altered phenotypes tumors. In our sample 10 Caucasian patients with carcinoma, semiquantitative analysis was performed loci DRB1 DQB1 malignant normal tissue. Gene amplifications were identified 62.5% analyzed alleles deletions 17.5%, demonstrating that genomic aberrations 6p21.3 common copy number gain more frequent than loss. Moreover, most pronounced advanced-stage evaluate genotype-phenotype relation, immunohistochemical analyses revealed de novo 30% tumors an inverse association between antigen level HLA number. It remains be elucidated whether profound changes latter quantities result host's immunological self-defense, indicate presence oncogene located within MHC-complex or merely reflect increasing loss differentiation

参考文章(49)
T. Cremer, M. Kiessling, R. G. Weber, F. K. Albert, C. Sommer, Clinically distinct subgroups of glioblastoma multiforme studied by comparative genomic hybridization. Laboratory Investigation. ,vol. 74, pp. 108- 119 ,(1996)
Douglas J. Schwartzentruber, Kathleen C. Barracchini, Yasmine M. Hijazi, Roya D. Dadmarz, Steven A. Rosenberg, Arnold Mixon, Aida Ordoubadi, Michael A. Steller, Carolyn O. Thompson, Tumor-infiltrating lymphocytes from human ovarian cancer patients recognize autologous tumor in an MHC class II-restricted fashion. The cancer journal from Scientific American. ,vol. 2, pp. 263- 272 ,(1996)
F. M. Burnet, The concept of immunological surveillance. Progress in Experimental Tumor Research. ,vol. 13, pp. 1- 27 ,(1970) , 10.1159/000386035
S Ostrand-Rosenberg, V Clements, A Thakur, Rejection of mouse sarcoma cells after transfection of MHC class II genes. Journal of Immunology. ,vol. 144, pp. 4068- 4071 ,(1990)
V C Suraj, T L Bugawan, H A Erlich, N Fildes, G R McClure, W Klitz, R C Helmuth, A B Begovich, Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. Journal of Immunology. ,vol. 148, pp. 249- 258 ,(1992)
C Ober, K van der Ven, HLA-G polymorphisms in African Americans. Journal of Immunology. ,vol. 153, pp. 5628- 5633 ,(1994)
R Versteeg, C van der Minne, A Plomp, A Sijts, A van Leeuwen, P Schrier, N-myc expression switched off and class I human leukocyte antigen expression switched on after somatic cell fusion of neuroblastoma cells. Molecular and Cellular Biology. ,vol. 10, pp. 5416- 5423 ,(1990) , 10.1128/MCB.10.10.5416
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster, Frits R. Rosendaal, Richard J. Dirven, Hans de Ronde, Pieter A. van der Velden, Pieter H. Reitsma, Mutation in blood coagulation factor V associated with resistance to activated protein C Nature. ,vol. 369, pp. 64- 67 ,(1994) , 10.1038/369064A0
L De Zen, A Orfao, G Cazzaniga, L Masiero, MG Cocito, M Spinelli, A Rivolta, A Biondi, L Zanesco, G Basso, Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification. Leukemia. ,vol. 14, pp. 1225- 1231 ,(2000) , 10.1038/SJ.LEU.2401824